Indi Molecular Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Indi Molecular Inc.
June venture capital financings for emerging companies totaled more than $688.8m, ranging from an undisclosed round for Avitide to a $120m Series B for Rubius Therapeutics.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Radiopharmaceuticals, Contrast Agents
- Large Molecule